Literature DB >> 4820890

Concealed bypasses of the atrioventricular mode in patients with paroxysmal supraventricular tachycardia revealed by intracardiac electrical stimulation and verapamil.

R A Spurrell, D M Krikler, E Sowton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4820890     DOI: 10.1016/0002-9149(74)90247-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  14 in total

1.  Fast pathway-His bundle connections in the rabbit heart.

Authors:  Eugene Patterson; Benjamin J Scherlag
Journal:  J Interv Card Electrophysiol       Date:  2004-04       Impact factor: 1.900

2.  Concealed accessory pathways: Historical notes.

Authors:  G H von Knorre; B Ismer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-03

Review 3.  Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?

Authors:  H O Klein; E Kaplinsky
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

4.  Electrocardiography then and now: where next?

Authors:  D M Krikler
Journal:  Br Heart J       Date:  1987-02

5.  Evidence for a unidirectional retrograde communication between distal His bundle and atria.

Authors:  J W Mason
Journal:  Br Heart J       Date:  1980-05

6.  Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.

Authors:  H J Wellens; S L Tan; F W Bär; D R Düren; K I Lie; H M Dohmen
Journal:  Br Heart J       Date:  1977-10

7.  Patterns of atrial activation during right ventricular pacing in patients with concealed left-sided Kent pathways.

Authors:  D E Ward; A J Camm; R A Spurrell
Journal:  Br Heart J       Date:  1979-08

Review 8.  The therapeutic and diagnostic cardiac electrophysiological uses of adenosine.

Authors:  A D Malcolm; C J Garratt; A J Camm
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

Review 9.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

10.  Acute prolongation of myocardial refractoriness by sotalol.

Authors:  D H Bennett
Journal:  Br Heart J       Date:  1982-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.